Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.79 |
| ▸ | MAPT | P10636 | 10/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.67 |
| ▸ | HTT | P42858 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 4/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | GRK6 | P43250 | 1/20 | 0.62 |
| ▸ | GAPDH | P04406 | 1/20 | 0.61 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.61 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.61 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.59 |
| ▸ | USP7 | Q93009 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL686171 | 0.90 | AR (0.84) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL14582287 | 0.88 | KMT2A (0.80) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL23949811 | 0.88 | MAPT (0.81) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL681674 | 0.88 | MAPT (0.81) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL15300156 | 0.86 | AR (0.81) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL15299952 | 0.86 | AR (0.81) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL19406536 | 0.84 | AR (0.80) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL13608010 | 0.83 | AR (0.76) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL13601360 | 0.83 | AR (0.75) | ARMAPTKDM4EMEN1KMT2A | |
| SCHEMBL682724 | 0.82 | AR (0.74) | ARMAPTKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9452425-B2 | Compositions containing ionic liquids and their uses, in particular in organic synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-09-27 | — | — | US | disclosed |
| US-9452425-B2 | Compositions containing ionic liquids and their uses, in particular in organic synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-09-27 | — | — | US | disclosed |
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-12-31 | — | — | US | disclosed |
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2009-12-31 | — | — | US | disclosed |
| US-20070043234-A1 | Use of functionalized onium salts as a soluble support for organic synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-02-22 | — | — | US | disclosed |
| US-20070043234-A1 | Use of functionalized onium salts as a soluble support for organic synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090326228-A1 | COMPOSITIONS CONTAINING IONIC LIQUIDS AND THEIR USES, IN PARTICULAR IN ORGANIC SYNTHESIS | F12, ANXA1, F11 | AR 3458/4885MAPT 2026/4885KDM4E 4820/4885 |
| US-20070043234-A1 | Use of functionalized onium salts as a soluble support for organic synthesis | NOS1, NOS2, F12 | AR 1848/4885MAPT 862/4885KDM4E 4485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.